View the full article in PharmaTimes here. We are delighted to share that Zhana Kuncheva, PhD, Director of Health Data Science at bioXcelerate AI, has been featured in the May 2025 issue of PharmaTimes, where she explores the critical role of technology in reshaping how we approach preventative healthcare. The article, titled “Prevention is better… Continue reading Transforming Healthcare with AI-Driven Early Intervention
Tag: Bioxcelerate AI
How Integrated Expertise is Shaping the Future of Drug Discovery
View the full article in Drug Discovery News here. We are pleased to share that Manjula Dissanayake, PhD, Principal of Technology Innovation at bioXcelerate AI, has been featured in an article published by Drug Discovery News, exploring the transformative role of integrated expertise in shaping the future of drug discovery. The article, titled Breaking Down… Continue reading How Integrated Expertise is Shaping the Future of Drug Discovery
Dr Afyouni Discusses Effective Data Housekeeping in Drug Discovery
We are pleased to share that Soroosh Afyouni, PhD, Head of Health Data Sciences at bioXcelerate AI, has been featured in an insightful article discussing the critical role of effective data management in accelerating drug discovery and development. The article, titled Accelerating Drug Discovery and Development with Effective Data Housekeeping, explores how the vast and… Continue reading Dr Afyouni Discusses Effective Data Housekeeping in Drug Discovery
Unleashing the power of genomics with population scale proteomics
At the recent Nordic Conference on Future Health, Chris Foley PhD, our Managing Director and Chief Scientist, was a distinguished guest speaker at Olink’s workshop titled Navigating the UKB Plasma Proteomics Data to Explore Protein Variability, Disease Risk Scores, and Proteogenomic Associations. This workshop focused on the UK Biobank Pharma Proteomics Project (UKB-PPP), which stands… Continue reading Unleashing the power of genomics with population scale proteomics
Dr Afyouni Discusses AI in Healthcare at the RSSI
We are delighted to share that Dr Soroosh Afyouni, PhD, Head of Health Data Science at bioXcelerate AI, was a panellist at the Royal Statistical Society (RSS) International Conference 2024, to discuss AI in healthcare. The RSS Conference is the UK’s premier event for statistics and data science, bringing together over 600 professionals from more… Continue reading Dr Afyouni Discusses AI in Healthcare at the RSSI
Dr Zhana Kuncheva on the AI Revolution in Healthcare
We are excited to announce that Zhana Kuncheva, our Director of Health Data Science, recently published an insightful article in Pharma IQ titled “Unlocking Health Data’s Potential: The AI Revolution in Healthcare.” This article explores how artificial intelligence (AI) is transforming healthcare by unlocking the value hidden in vast data reserves, with a particular focus… Continue reading Dr Zhana Kuncheva on the AI Revolution in Healthcare
Breakthrough Research Spotlighted in Pharma IQ
Our Managing Director & Chief Scientist, Dr Chris Foley, and Dr Riccardo Marioni, Chair of Molecular Epidemiology of Ageing at the University of Edinburgh, were recently interviewed by Pharma IQ about their groundbreaking research. This study, a collaboration between bioXcelerate AI, Biogen, and the University of Edinburgh, marks a significant advancement in predictive health. In… Continue reading Breakthrough Research Spotlighted in Pharma IQ
Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank
View the full research paper on Nature Communications Objectives: This study aimed to explore how gene-environment interactions (GEIs) affect protein levels in the human body, specifically within the plasma proteome. The focus was on identifying variance quantitative trait loci (vQTLs) that signal these interactions, and understanding how genetic and environmental factors together influence protein expression.… Continue reading Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank
New Advances in Disease Risk Prediction
Objectives: The primary goal was to identify genetic variants linked to Alzheimer’s disease (AD) using advanced genomic techniques. The study aimed to enhance understanding of the genetic underpinnings of AD by employing sophisticated methods to analyse large-scale genomic data. Key objectives included pinpointing novel genetic variants associated with AD, elucidating their functional roles, and exploring… Continue reading New Advances in Disease Risk Prediction
isGWAS Showcased at ESHG2024 in Berlin
We are delighted to announce that bioXcelerate AI’s innovative work was showcased at the prestigious European Society of Human Genetics (ESHG) Conference in Berlin. The ESHG event is a key platform for geneticists from Europe and around the world to share breakthroughs and advancements in human genetics research. At the conference, Dr. Heiko Runz, a… Continue reading isGWAS Showcased at ESHG2024 in Berlin